<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Calcaterra SL</submitter><funding>NIDA NIH HHS</funding><funding>National Institute on Drug Abuse</funding><pagination>1065-1072</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8971245</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(5)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Hospitalizations related to the consequences of substance use are rising yet most hospitalized patients with substance use disorder do not receive evidence-based addiction treatment. Opportunities to leverage the hospitalist workforce could close this treatment gap.&lt;h4>Aim&lt;/h4>To describe the development, implementation, and evaluation of a hospitalist-directed addiction consultation service (ACS) to provide in-hospital addiction treatment.&lt;h4>Setting&lt;/h4>Six hundred fifty-bed university hospital in Aurora, Colorado.&lt;h4>Program description&lt;/h4>Hospitalists completed buprenorphine waiver training, participated in a 13-part addiction lecture series, and completed a minimum of 40 hours of online addiction training. Hospitalists participated in shadow shifts with an addiction-trained physician. Dedicated addiction social workers developed relationships with local addiction treatment services.&lt;h4>Program evaluation metrics&lt;/h4>Physician-related metrics included education, training, and clinical time spent in addiction practice. Patient and encounter-related metrics included a description of ACS care provision.&lt;h4>Results&lt;/h4>Eleven hospitalists completed an average of 95 hours of addiction-related didactics. Once addiction training was complete, hospitalists spent an average of 30 days over 12 months staffing a weekday ACS. Between October 2019 and November 2020, the ACS completed 1620 consultations on 1350 unique patients. Alcohol was the most common substance (n = 1279; 79%), followed by tobacco (979; 60.4%), methamphetamines/amphetamines (n = 494; 30.5%), and opioids (n = 400; 24.7%). Naltrexone was the most frequently prescribed medication (n = 350; 21.6%), followed by acamprosate (n = 93; 5.7%), and buprenorphine (n = 77, 4.8%). Trauma was a frequent discharge diagnoses (n = 1564; 96.5%). Leaving prior to treatment completion was commonly noted (n = 120, 7.4%). The ACS completed 47 in-hospital methadone enrollments.&lt;h4>Discussion&lt;/h4>The hospitalist-directed ACS is a promising clinical initiative that could be implemented to expand hospital-based addiction treatment. Future research is needed to understand challenges to disseminating this model into other hospital settings, and to evaluate intended and unintended effects of broad implementation.</pubmed_abstract><journal>Journal of general internal medicine</journal><pubmed_title>The Development and Implementation of a Hospitalist-Directed Addiction Medicine Consultation Service to Address a Treatment Gap.</pubmed_title><pmcid>PMC8971245</pmcid><funding_grant_id>K08 DA049905</funding_grant_id><funding_grant_id>K08DA049905</funding_grant_id><pubmed_authors>McBeth L</pubmed_authors><pubmed_authors>Burden M</pubmed_authors><pubmed_authors>Calcaterra SL</pubmed_authors><pubmed_authors>Keniston AM</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Development and Implementation of a Hospitalist-Directed Addiction Medicine Consultation Service to Address a Treatment Gap.</name><description>&lt;h4>Introduction&lt;/h4>Hospitalizations related to the consequences of substance use are rising yet most hospitalized patients with substance use disorder do not receive evidence-based addiction treatment. Opportunities to leverage the hospitalist workforce could close this treatment gap.&lt;h4>Aim&lt;/h4>To describe the development, implementation, and evaluation of a hospitalist-directed addiction consultation service (ACS) to provide in-hospital addiction treatment.&lt;h4>Setting&lt;/h4>Six hundred fifty-bed university hospital in Aurora, Colorado.&lt;h4>Program description&lt;/h4>Hospitalists completed buprenorphine waiver training, participated in a 13-part addiction lecture series, and completed a minimum of 40 hours of online addiction training. Hospitalists participated in shadow shifts with an addiction-trained physician. Dedicated addiction social workers developed relationships with local addiction treatment services.&lt;h4>Program evaluation metrics&lt;/h4>Physician-related metrics included education, training, and clinical time spent in addiction practice. Patient and encounter-related metrics included a description of ACS care provision.&lt;h4>Results&lt;/h4>Eleven hospitalists completed an average of 95 hours of addiction-related didactics. Once addiction training was complete, hospitalists spent an average of 30 days over 12 months staffing a weekday ACS. Between October 2019 and November 2020, the ACS completed 1620 consultations on 1350 unique patients. Alcohol was the most common substance (n = 1279; 79%), followed by tobacco (979; 60.4%), methamphetamines/amphetamines (n = 494; 30.5%), and opioids (n = 400; 24.7%). Naltrexone was the most frequently prescribed medication (n = 350; 21.6%), followed by acamprosate (n = 93; 5.7%), and buprenorphine (n = 77, 4.8%). Trauma was a frequent discharge diagnoses (n = 1564; 96.5%). Leaving prior to treatment completion was commonly noted (n = 120, 7.4%). The ACS completed 47 in-hospital methadone enrollments.&lt;h4>Discussion&lt;/h4>The hospitalist-directed ACS is a promising clinical initiative that could be implemented to expand hospital-based addiction treatment. Future research is needed to understand challenges to disseminating this model into other hospital settings, and to evaluate intended and unintended effects of broad implementation.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-05-29T19:46:05.436Z</modification><creation>2025-05-29T19:46:05.436Z</creation></dates><accession>S-EPMC8971245</accession><cross_references><pubmed>34013473</pubmed><doi>10.1007/s11606-021-06849-8</doi></cross_references></HashMap>